23andMe Idiopathic Pulmonary Fibrosis Research Study
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 690
- 试验地点
- 1
- 主要终点
- IPF Symptom Progression 6 month follow-up
研究概览
简要总结
The long term goal of this study is to increase genetic understanding of IPF to enable the development of an effective drug for IPF that can improve the lives of those living with the condition.
详细描述
This study will recruit 1,000 people who have been diagnosed with IPF or Hermansky-Pudlak syndrome (HPS). Eligible participants who consent to participate in 23andMe Research and the IPF Research Study will receive a 23andMe Health + Ancestry kit at no cost. Participants will provide a saliva sample and take a baseline survey online answering questions about their disease diagnosis, testing, treatment, and symptoms. Participants will also be asked to take the same survey 3, 6, and 9 months after completing the baseline survey. The data collected from this study will be incorporated into the 23andMe Database and used to better understand the underlying genetic and environmental factors that contribute to IPF.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Have been diagnosed with IPF or Hermansky-Pudlak syndrome (HPS)
- •Are 18+ years old
- •Live in the US
排除标准
- •Have been diagnosed with sarcoidosis or hypersensitivity pneumonitis
结局指标
主要结局
IPF Symptom Progression 6 month follow-up
时间窗: 6 months post baseline
Survey asking about disease diagnosis, testing, treatments, and symptom progression
IPF Symptom Progression 9 month follow-up
时间窗: 9 months post baseline
Survey asking about disease diagnosis, testing, treatments, and symptom progression
IPF Symptom Progression 3 month follow-up
时间窗: 3 months post baseline
IPF Symptom Progression 3 month follow-up
IPF Symptom Progression Baseline
时间窗: Baseline
Survey asking about disease diagnosis, testing, treatments, and symptom progression
次要结局
未报告次要终点